FLOMAX
LOE ApproachingNDAORALCAPSULE
Approved
Apr 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
Drug data last refreshed 17h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLOMAX (tamsulosin) is an alpha-1A adrenoceptor antagonist oral capsule approved in 1997 for benign prostatic hyperplasia (BPH). It works by blocking alpha-1A receptors in the prostate and bladder neck to relax smooth muscle, improving urine flow and reducing BPH symptoms. The drug targets the dynamic component of urethral obstruction caused by smooth muscle constriction.
$0.002BPart D
LOE ApproachingDeclining
Product is in late-stage maturity with minimal Part D spending ($2M, 2823 claims in 2023), signaling a shrinking brand team and reduced commercial investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (7)
Exploration of Pupil Dilation in Horner's Patients Taking Flomax
Started Sep 2018
1 enrolled
Horner Syndrome
A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
Started Oct 2007
81 enrolled
Prostatic Hyperplasia
Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis
Started Nov 2005
60 enrolled
Prostate Cancer Patients Undergoing External Radiation and Seed Implantation
Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms
Started May 2001
74 enrolled
Lower Urinary Tract Symptoms
FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)
Started Mar 2001
176 enrolled
Prostate Hyperplasia
Worked on FLOMAX at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.